This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by de los Reyes, E. Articles by Mrak, R. E. Search for Related Content PubMed PubMed Citation Articles by de los Reyes, E. Articles by Mrak, R. E. Social Bookmarking                         What's this?

Profound Infantile Neuroretinal Dysfunction in a Heterozygote for the CLN3 Genetic Defect

Department of Pediatrics University of Arkansas for the Medical Sciences Little Rock, Arkansas Department of Pediatrics Children's Hospital Columbus, Ohio, delosreyese{at}pediatrics.ohio-state.edu.

Paul Richard Dyken, MD

Institute for Research in Childhood Neurodegenerative Diseases Mobile, Alabama

Paul Phillips, MD

Department of Opthalmology and Pediatrics University of Arkansas for the Medical Sciences Little Rock, Arkansas

Michael Brodsky, MD

Department of Opthalmology and Pediatrics, University of Arkansas for the Medical Sciences, Little Rock, Arkansas

Stephen Bates, MD

Department of Pediatrics, University Arkansas for the Medical Sciences, Little Rock, Arkansas

Charles Glasier, MD

Department of Radiology, University of Arkansas for the Medical Sciences, Little Rock, Arkansas

Robert E. Mrak, MD, PhD

Department of Pathology, University of Arkansas for the Medical Sciences, Little Rock, Arkansas

The neuronal ceroid-lipofuscinoses are a group of diseases that are characterized by progressive neuroretinal symptomatology, progressive accumulation of autofluorescing waxy lipopigments (ceroid-lipofuscin) within the brain and other tissues, and cerebral atrophy. Juvenile neuronal ceroid-lipofuscinosis, or Batten disease, is a form of neuronal ceroid-lipofuscinosis that is characterized by onset of neuroretinal symptoms between 4 and 10 years. Juvenile neuronal ceroid-lipofuscinosis is the most common type of neuronal ceroid-lipofuscinosis in the United States and Europe and is inherited as an autosomal recessive genetic disorder. Research in the last decade has led to the identification of the responsible gene for juvenile neuronal ceroid-lipofuscinosis, which is designated as CLN3. CLN3 is located on chromosome 16p11.2-12.1. The major mutation is a 1.02 kb deletion, which removes exons 7 and 8. Both homozygotic and heterozygotic deletions at the CLN3 gene site have been associated with the clinical syndromes of juvenile neuronal ceroid-lipofuscinosis. We report a possible atypical case of neuronal ceroid-lipofuscinosis, an infant, who presented at 5 months of age with a lack of developmental milestones, poor vision, severe retinopathy, intractable seizures, and progressive cerebral atrophy. Extensive laboratory investigations, including thorough metabolic evaluations, were unremarkable except for neuroimaging studies, electroencephalography, and electroretinography, all of which showed abnormalities confirming both cerebral and retinal degeneration. Although skin and conjunctival biopsies did not show classic fingerprint cytosomes by electron microscopic study, which characterize juvenile neuronal ceroid-lipofuscinosis, a diagnosis of an atypical form of juvenile neuronal ceroid-lipofuscinosis was suspected on the basis of the clinical picture. The retinal abnormalities, surprisingly, were those believed to be diagnostic of juvenile-onset neuronal ceroid-lipofuscinosis, or Batten disease. Subsequently, a heterozygous mutation for the common 1.02 kb deletion characteristic of juvenile neuronal ceroid-lipofuscinosis was established. (J Child Neurol 2004;19:42—46).

Journal of Child Neurology, Vol. 19, No. 1, 42-46 (2004)
DOI: 10.1177/08830738040190010703


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?